Corrado Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Corrado Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,831	Closed	-$731K	–	107
2024 Q4	$731K	Buy	18,831 +2,775	+17%	+$117K	0.48%	81
2024 Q3	$723K	Buy	16,056 +473	+3%	+$21.1K	0.45%	79
2024 Q2	$651K	Buy	15,583 +973	+7%	+$40.7K	0.42%	83
2024 Q1	$665K	Buy	14,610 +808	+6%	+$36.8K	0.44%	75
2023 Q4	$638K	Buy	+13,802	New	+$563K	0.52%	61

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Corrado Advisors's GNOM Position: Q1 2025 in Review

Corrado Advisors sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 18,831 shares — an estimated $731K sold.

Corrado Advisors first reported a position in GNOM in Q4 2023 and held it in 5 quarters. The position peaked at $731K in Q4 2024. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

Corrado Advisors reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Corrado Advisors sold 18,831 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $731K.
Corrado Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and held it in 5 quarters.
Corrado Advisors's Global X Genomics & Biotechnology ETF position peaked at $731K in Q4 2024.
60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on Corrado Advisors's 13F filing for Q1 2025, filed 1 May 2025.